Biotech-310x175_copy

What were the top 20 M&A deals in pharma and biotech sector...

  • China
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing acute scarcity. This is making them seek... Read more

Biotech-310x175_copy

What were the top 20 global M&A transactions of 2012?

  • Singapore
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing acute scarcity. This is making them seek... Read more

apac-witnesses-mergers-acquisitions-m-a-galore-during-q1-2013

What are the key mergers & acquisitions of Q1 2013?

  • India
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The big players of the industry are thus looking... Read more

m-a-analysis-biospectrum-asia-top-20-survey

Why did mergers & acquisitions plunge in APAC?

  • China
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 billion, which is about 10 percent lower than the... Read more

sgs-expands-services-towards-biologics-testing

Samsung forays into medtech market in India

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Samsung India strengthened its presence in the health and medical equipment business in the country by launching digital radiology and in-vitro diagnostics equipment... Read more

analytica-gets-letter-of-intent-from-taiwan-allied-dragon-tad

Ahn-Gook to distribute EffRx's Binosto in Korea

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: EffRx Pharmaceuticals announced the signing of an exclusive distribution agreement with Ahn-Gook Pharmaceutical for Binosto - EffRx's innovative osteoporosis... Read more

16b-biospectrum-asia-top-20-survey-rank-16-dong-a-pharmaceutical-south-korea

Dong-A Pharma diversifies portfolio to include biosimilars...

  • Korea
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Clocking revenues of $995.40 million, Dong-A pharmaceutical is acknowledged as a leading name in Korea's pharmaceutical industry. Over the years, the company has... Read more

biocnd-and-genor-biopharma-biosimilars-deal-in-south-korea

Biocnd, Genor develop Humira, Herceptin biosimilars

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Mr David Song, president and CEO, Biocnd, signed an agreement with Dr Joe Zhou, CEO, Genor Biopharma, for the co-development of two monoclonal antibody... Read more

japan-south-korea-thailand-and-the-eu-are-taking-action-to-prevent-import-of-the-gm-wheat-from-the-us

Japan, Korea suspend wheat import from the US

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japan partially suspended imports of wheat from the US on Friday after the US government revealed that a strain of genetically engineered wheat, which... Read more

Previous 1 3 4 5 6 7

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X